Connect with us

HEALTH NEWS

Pfizer agrees to let its Covid-19 pill be made and sold in 95 countries

Published

on

Pfizer agrees to let its Covid-19 pill be made and sold in 95 countries

In a statement, Pfizer stated that it would grant a license for the antiviral pill to Geneva-based Medicines Patent Pool that would allow generic drug firms to produce the pill for use in the 95 countries that make up about 53 per cent of the world’s population.

Pfizer will sell the pills it manufactures under the brand name Paxlovid.

“Pfizer remains committed to bringing forth scientific breakthroughs to help end this pandemic for all people. We believe oral antiviral treatments can play a vital role in reducing the severity of Covid-19 infections, decreasing the strain on our healthcare systems and saving lives,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer.

“We must work to ensure that all people regardless of where they live or their circumstances, have access to these breakthroughs, and we are pleased to be able to work with MPP to further our commitment to equity,” he added.

“This license is so important because, if authorized or approved, this oral drug is particularly well-suited for low- and middle-income countries and could play a critical role in saving lives, contributing to global efforts to fight the current pandemic,” said Charles Gore, Executive Director of MPP.

“It’s quite significant that we will be able to provide access to a drug that appears to be effective and has just been developed, to more than 4 billion people,” Esteban Burrone, head of policy at the MPP, said.

HEALTH NEWS

Airborne transmission of Covid-19 random, social distancing alone not enough to control spread: Study

Published

on

By

A new study new study has shown that the airborne transmission of Covid-19 is highly random and suggests that social distancing alone is not effective in controlling its spread, reiterating the importance of vaccination and face masks.

“One part of the way that this disease spreads is virology: how much virus you have in your body, how many viral particles you expel when you speak or cough,” said Dr Shrey Trivedi, the Indian-origin first author of the study published in the journal ‘Physics of Fluids’ this week.

“But another part of it is fluid mechanics: what happens to the droplets once they’re expelled, which is where we come in. As fluid mechanics specialists, we like the bridge from virology of the emitter to the virology of the receiver and we can help with risk assessment,” explained Trivedi from the Department of Engineering at the University of Cambridge.

Continue Reading

HEALTH NEWS

France likely to announce Covid-19 booster shots for all adults: Report

Published

on

By

As per reports, France is expected to announce that Covid-19 booster shots will be made available to all adults, as well as stricter rules on wearing face masks and more stringent health pass checks to curb a new wave of infections.

President Emmanuel Macron’s government on Wednesday said it would focus on tougher social distancing rules and a faster booster shot programme and that it wanted to avoid the lockdowns being imposed once more by some other European countries.

Continue Reading

HEALTH NEWS

Air pollution linked to increased risk of getting sick from Covid-19: Study

Published

on

By

According to a study conducted in Spain, long-term exposure to air pollution is associated with an increased risk of developing Covid-19 among people who get infected with the SARS-CoV-2 virus.

The research, published in the journal Environment Health Perspectives on Wednesday, provides further evidence on the health benefits of reducing air pollution, and highlights the influence of environmental factors on infectious diseases.

“The problem is that previous studies were based on reported cases, which had been diagnosed, but missed all the asymptomatic or undiagnosed cases,” said study first-author Manolis Kogevinas from Barcelona Institute of Global Health (ISGlobal) in Spain.

Continue Reading

Trending